Cuprina Holdings (Cayman) (CUPR) Liabilities and Shareholders Equity (2023 - 2025)
Cuprina Holdings (Cayman)'s (CUPR) quarterly Liabilities and Shareholders Equity came in at $8.3 million in Q2 2025, up 533.71% on a QoQ basis from $1.3 million in Q4 2024.
Cuprina Holdings (Cayman) (CUPR) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends
Cuprina Holdings (Cayman) (CUPR) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $8.3 million in Q2 2025.
- Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $8.3 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $10.8 million (changed N/A YoY) and the FY2024 annual result came in at $1.3 million, up 11.22% from the prior year.
- Liabilities and Shareholders Equity climbed to $8.3 million in Q2 2025, from $1.3 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $8.3 million in Q2 2025 to a low of $1.2 million in Q4 2023.
- A 3-year average of $3.6 million and a median of $1.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The widest YoY moves for Liabilities and Shareholders Equity: up 11.69% in 2024, down 11.69% in 2024.
- Tracing CUPR's Liabilities and Shareholders Equity over 3 years: stood at $1.2 million in 2023, then gained by 11.69% to $1.3 million in 2024, then jumped by 533.71% to $8.3 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $8.3 million (Q2 2025), $1.3 million (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Cuprina Holdings (Cayman) | 7.40 Mn | 7.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8.31 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.17 Mn |